JTCS Concomitant Website
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Marco Pocar
Francesco Donatelli
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pocar, M.
Right arrow Articles by Donatelli, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pocar, M.
Right arrow Articles by Donatelli, F.
Related Collections
Right arrow Cardiac - other

J Thorac Cardiovasc Surg 2004;128:327-328
© 2004 The American Association for Thoracic Surgery


Letter to the editor

Use of enoxaparin in cardiac surgery

Marco Pocar, MD, PhDa, Alessio Assaghi, MDa, Francesco Donatelli, MDa

a Cattedra di Cardiochirurgia, Università degli Studi di Milano, Policlinico MultiMedica, Milan, Italy

The first 20% of the full text of this article appears below.

To the Editor:

We congratulate Dr Medalion and coworkers1 for the results reported in their study recently published in the Journal that focused on the effects of enoxaparin in patients undergoing coronary operations. The optimal administration of low-molecular-weight heparin in cardiac surgery is a controversial issue.2,3 The use of enoxaparin in patients with prosthetic valves has also been recently described.4,5 Because we have routinely used enoxaparin both preoperatively and postoperatively in nonemergency cardiac patients at our institution during the last 5 years, we would like to outline some aspects of our experience.

When we started using enoxaparin in 1998, we had some concerns related to . . . [Full Text of this Article]







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2004 by The American Association for Thoracic Surgery.